Visa is acquiring BioCatch, a company specializing in behavioral biometrics, for $2.4 billion. The deal, reported by Crypto Briefing, is aimed at enhancing fraud detection by analyzing how users interact with devices — things like typing rhythm, mouse movements, and even how they hold a phone. It could set new security benchmarks for financial transactions, with potential ripple effects for the crypto industry.
What BioCatch does
BioCatch builds software that watches user behavior in real time. Instead of relying solely on passwords or one-time codes, it looks at patterns — the angle of a swipe, the speed of keystrokes, the way a person scrolls. If something feels off, the system flags it as potential fraud. The technology is already used by some of the largest banks and payment processors.
Why Visa is buying
Visa processes trillions of dollars in payments every year. Fraud is a constant cost, and the company has been investing heavily in machine learning and AI to cut down on false positives and catch bad actors faster. BioCatch gives Visa a layer of security that doesn't depend on what a user knows or has — it depends on who they are, behaviorally. That's hard to fake.
Crypto implications
Crypto exchanges and wallet providers face similar fraud challenges, from account takeovers to phishing. Behavioral biometrics is already creeping into the space, but a Visa-backed push could accelerate adoption. If Visa integrates BioCatch into its network, crypto platforms that rely on Visa for on-ramps and off-ramps may end up using the tech too. The deal also signals that behavioral biometrics is becoming a standard tool, not a niche one.
At $2.4 billion, this is one of the larger acquisitions in the fintech security space this year. It shows Visa is willing to pay up for technology that protects its ecosystem. Competitors like Mastercard and PayPal are likely watching closely. For crypto, the message is clear: the security bar is rising, and behavioral data is part of the answer.
The acquisition was first reported by Crypto Briefing. No timeline for closing has been announced, but the deal is expected to face regulatory review in multiple jurisdictions.
